Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
19.10
+0.73 (3.97%)
Jul 21, 2026, 4:00 PM EDT - Market closed

AAPG Revenue

In the year 2025, Ascentage Pharma Group International had annual revenue of 574.12M CNY, down -41.46%. Ascentage Pharma Group International had revenue of 340.42M in the half year ending December 31, 2025, with 329.37% growth.

Revenue (ttm)
574.12M CNY
Revenue Growth
-41.46%
P/S Ratio
20.95
Revenue / Employee
748,527 CNY
Employees
767
Market Cap
1.72B USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025574.12M-406.53M-41.46%
Dec 31, 2024980.65M758.67M341.77%
Dec 31, 2023221.98M12.27M5.85%
Dec 31, 2022209.71M181.80M651.38%
Dec 31, 202127.91M15.46M124.18%
Dec 31, 202012.45M-2.06M-14.21%
Dec 31, 201914.51M7.71M113.21%
Dec 31, 20186.81M479.00K7.57%
Dec 31, 20176.33M-1.34M-17.46%
Dec 31, 20167.67M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Fortrea Holdings2.71B
Innoviva420.69M
Immunocore Holdings412.81M
AnaptysBio232.39M
Zymeworks81.26M
Intellia Therapeutics66.09M
Vir Biotechnology65.50M
Precigen31.60M
Revenue Rankings